about
The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disordersRole of HIV in amyloid metabolismExpression of neprilysin in skeletal muscle reduces amyloid burden in a transgenic mouse model of Alzheimer diseaseCirculating neprilysin clears brain amyloidIncreased accumulation of intraneuronal amyloid beta in HIV-infected patients.Degradation of islet amyloid polypeptide by neprilysin.HIV-1 Tat contributes to Alzheimer's disease-like pathology in PSAPP miceThe comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART eraHost and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders.Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection.Infectious agents and neurodegeneration.An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?HIV-1 Tat-induced cerebrovascular toxicity is enhanced in mice with amyloid deposits.HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide.HIV Tat protein and amyloid-β peptide form multifibrillar structures that cause neurotoxicity.HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures.HIV-1 reduces Abeta-degrading enzymatic activities in primary human mononuclear phagocytesBiomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C.Neprilysin in the cerebrospinal fluid and serum of patients infected with HIV1- subtypes C and B.Withaferin A Suppresses Beta Amyloid in APP Expressing Cells: Studies for Tat and Cocaine Associated Neurological DysfunctionsHIV Neuroinfection and Alzheimer's Disease: Similarities and Potential Links?
P2860
Q26777952-F179C02B-C8D1-47CE-84C6-102A937522CFQ26824179-167D25C7-E302-4484-8FDE-6605DCA6273BQ33713881-562AC557-B2CB-4BB0-8838-0D2125B353E8Q34071954-9FB6F163-42B8-479C-9877-0F006CEC1F28Q34661343-CA434B24-138C-4D12-8B05-25118BF87619Q36862586-E18C713B-AA24-4F47-AB19-0E0B5D28ACAAQ37127012-28F977C1-665E-4FD2-B62C-76D0A538D9EFQ37193610-6E41C4F4-8ADA-4C8C-9088-AA66B5997F0CQ37416015-BBD6D87B-8219-4DD1-ACFB-2798F8B711D4Q37692508-924BC640-1524-43FD-AEC5-0099233BA8B3Q37848266-2E763880-174D-46C1-B0F5-94D4319711B5Q38628801-60A55D90-1B5B-4EAC-9FF5-288C4B90D17FQ38906535-73CC15E8-20C4-43A9-9C94-03A8178896FAQ40048514-D9DD5DCB-A4D1-4369-B173-2C55307B366DQ40325425-6BA92A00-0448-4B0E-9706-A81CCD9A29E9Q40701277-3E375568-85F0-4E14-9BE5-B599F615A493Q42130528-7A9C70F2-E2F5-461F-9AB9-9C7A8BF5850FQ46790788-714FCD46-5E43-4ADC-8BF2-269CA1051532Q52730355-1290867A-2D13-4E62-ABC8-FF626821AB41Q57821144-8B0FF815-E26E-44CF-9AF7-0A69CC85AD0CQ58750745-7AD4712D-BFA6-4F07-9866-C500DC32FB93
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Tat peptides inhibit neprilysin.
@en
Tat peptides inhibit neprilysin.
@nl
type
label
Tat peptides inhibit neprilysin.
@en
Tat peptides inhibit neprilysin.
@nl
prefLabel
Tat peptides inhibit neprilysin.
@en
Tat peptides inhibit neprilysin.
@nl
P2093
P1476
Tat peptides inhibit neprilysin.
@en
P2093
Abigail Daily
Avindra Nath
Louis B Hersh
P2888
P304
P356
10.1080/13550280600760677
P577
2006-06-01T00:00:00Z
P6179
1004929179